Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
As the race for the next "blockbuster pill" intensifies, R&D teams are under pressure to identify "me-too" or "me-better" scaffolds while avoiding Eli Lillys massive patent thicket
A: Weight-loss medications are not short-term medications
The approvalGerons first after 34 years in businesswas supported by data from the Phase III IMerge trial, in which patients on Rytelo had significantly higher rates of red blood cell transfusion independence over placebo for at least 24 weeks28% in the treatment arm versus 3% on placebo
YamamotoWRBoneRNSohnPSyedFReissausCAMosleyALet al
US$ 26.03
US$ 24.40
US$ 29.43
-1775582746855.png&w=384&q=75)
US$ 25.25
US$ 21.43
US$ 22.73
US$ 23.03
US$ 24.30
US$ 26.90
